E202G
Category 4 — Stable Fold, Function DisruptedPathogenic/Likely pathogenicCytoplasmic · predictedEditorialGlutamate-to-glycine substitution in wolframin's N-terminal cytoplasmic ATP6V1A-interaction region — a low AlphaMissense score (0.283, Likely Benign) sits in tension with the ClinVar Pathogenic/Likely pathogenic classification, requiring careful interpretation.
Interactive 3D Structure
Bond changes · DynaMut2 interaction analysis
| Interaction type | Wild-type partner | Mutant partner | Status |
|---|---|---|---|
| Hydrogen bond | A198 | A198 | Preserved |
| Polar contact | A198 | A198 | Preserved |
| Polar contact | E199 | E199 | Preserved |
| Polar contact | V204 | V204 | Preserved |
Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.
Computational Predictions
Clinical Evidence
Observed at very low frequency in gnomAD.
Structural Context
E202 is held between Asn203 (2.46 Angstrom) and Leu201 (2.46 Angstrom) covalently, with through-space contacts to Ala198 (3.93 Angstrom), Glu199 (3.96 Angstrom), Val204 (4.36 Angstrom), and Leu200 (4.57 Angstrom). The local environment is mixed polar-aliphatic: two leucines, an alanine, a valine, an asparagine, and another glutamate (E199) within 4.5 Angstrom. The Glu199-Glu202 pair is interesting — two negatively charged carboxylates within 4 Angstrom likely participate in a coordinated electrostatic feature, either repelling each other to maintain extended conformation or both coordinating a divalent metal cation or a positively charged binding partner.
The E202G substitution removes the side chain entirely. Glycine introduces backbone freedom where the wild-type maintained a side-chain-rigidified conformation. The Glu199-Glu202 coordinated electrostatic feature is destroyed — only Glu199 remains. If the wild-type pair coordinated a cation or formed part of an ATP6V1A-binding salt-bridge interface, that functionality is now lost.
DynaMut2 reports DeltaDeltaG = -0.19 kcal/mol — essentially unchanged. AlphaMissense, however, scores E202G at 0.283 (Likely Benign by the AM classifier). This is a notable discordance with ClinVar's Pathogenic/Likely pathogenic classification. Three possible reconciliations: (a) the AM model under-weighs charge-removal mutations in surface-exposed regions; (b) ClinVar evidence for E202G derives from a small number of affected families and may include linkage to a separate causal variant; (c) the variant is genuinely a partial loss-of-function with subtle cellular consequences that AM does not detect.
The structural signature — a Glu pair at the ATP6V1A-binding interface, broken by removal of one Glu — is functionally plausible. The Atlas should flag E202G as a discordant-metric variant requiring careful clinical follow-up rather than confident druggability assignment.
Druggability Assessment
Why this matters
Feed this card to Wolfram Intelligence
Download the E202G PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.